C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,508 | -52,342 | -26,322 | -105,316 | -70,743 |
| Depreciation Amortization | -348 | -293 | -327 | -3,578 | -2,977 |
| Accounts receivable | -3,440 | 901 | -4,926 | 8,697 | 1,458 |
| Accounts payable and accrued liabilities | 4 | 889 | -645 | -119 | 57 |
| Other Working Capital | -22,601 | -6,571 | -13,818 | 7,648 | 225 |
| Other Operating Activity | 34,344 | 12,074 | 12,753 | 27,511 | 24,755 |
| Operating Cash Flow | $-76,549 | $-45,342 | $-33,285 | $-65,157 | $-47,225 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -94,003 | -47,320 | -25,640 | -51,090 | -243,537 |
| PPE Investments | -596 | -185 | N/A | -180 | -184 |
| Sale Of Investment | 166,731 | 115,551 | 54,765 | N/A | 178,781 |
| Investing Cash Flow | $72,132 | $68,046 | $29,125 | $-51,270 | $-64,940 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,633 | 0 | 0 | 45,148 | 45,037 |
| Common Stock Repurchased | -179 | -155 | -155 | -194 | -194 |
| Other Financing Activity | 273 | 109 | 109 | 382 | 381 |
| Financing Cash Flow | $7,727 | $-46 | $-46 | $45,336 | $45,224 |
| Beginning Cash Position | 58,942 | 58,942 | 58,942 | 130,033 | 130,033 |
| End Cash Position | 62,252 | 81,600 | 54,736 | 58,942 | 63,092 |
| Net Cash Flow | $3,310 | $22,658 | $-4,206 | $-71,091 | $-66,941 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,549 | -45,342 | -33,285 | -65,157 | -47,225 |
| Capital Expenditure | -596 | -185 | N/A | -180 | -184 |
| Free Cash Flow | -77,145 | -45,527 | -33,285 | -65,337 | -47,409 |